Company profile

Delft Imaging

End-to-end diagnostic solutions bringing quality screening to those who need it most

Medical Imaging & Radiology

Company profile

About Delft Imaging

Delft Imaging is a Netherlands-based social enterprise that develops end-to-end diagnostic solutions designed to bring quality healthcare screening to underserved populations in resource-constrained settings. The company specializes in lung health and maternal health screening, combining portable and mobile X-ray systems with artificial intelligence to enable early detection in hard-to-reach places. Their technology portfolio includes CAD4TB+, an AI system for TB and lung health screening that analyzes chest X-rays within seconds with high accuracy and operates offline. For maternal health, they offer BabyChecker, an AI-enabled ultrasound screening solution. The company also provides a range of X-ray equipment from ultra-portable units to stationary systems, as well as mobile clinic solutions including the Delft Cruiser and Delft TukTuk for remote and densely populated areas respectively. Delft Imaging operates as a B Corp certified social enterprise and is a member of the Million Lives Collective. They work with national TB screening programs, health systems, and community-based organizations to build scalable and sustainable screening models. Their solutions integrate with existing health infrastructure to support decentralized screening, disease surveillance, and occupational health programs. With over 3,000 solutions deployed across 90+ countries, they have reached more than 55 million people worldwide, focusing particularly on key and vulnerable populations in Africa, Asia, Americas, and other regions.

Company description Delft Imaging official website

Mission. We are a social enterprise, driven by the belief that quality healthcare should not depend on location or infrastructure. Our innovations are designed to respond to pressing healthcare needs, particularly those of key and vulnerable populations in resource-constrained settings.

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Delft Imaging?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • lung health
  • maternal health
  • occupational lung disease
  • pregnancy complications
  • tuberculosis

Who it serves

  • Community-based organizations
  • Government
  • Health Systems
  • National screening programs

Deployment & integration

Embedded · On Premise deployment with recorded integration context.

Geographic context

MarketsAfrica · Americas · Asia · Central Asia · Europe · Middle East · Oceania
Company sourceOfficial website

Company milestones

Platform expansion

2025 Impact Report released, CAD4TB+ launched (unifying TB detection and surveillance), Florent Geerts named to TIME's 2026 TIME100 Health

Partnerships

Recorded partners

  • local health infrastructure partners
  • Million Lives Collective
  • national TB screening programs

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

BabyChecker

AI for pregnancy screening with ultrasound

Software · EmbeddedCompany source

CAD4TB+

AI for lung health and TB screening

Software · EmbeddedCompany source

CompassDR

X-ray for high-quality diagnostic imaging

Device · On PremiseCompany source

Delft Cruiser

Reliable screening in remote regions

Device · On PremiseCompany source

Delft Light

Portable, easy-to-setup X-ray

Device · On PremiseCompany source

Delft MAC

Easy transport and flexible positioning mobile X-ray

Device · On PremiseCompany source

Delft TukTuk

Screening solution in densely populated areas

Device · On PremiseCompany source

Delft Ultra

Ultra portable, high-quality X-ray

Device · On PremiseCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

55+ million people reached

global screening programs

3,000+ solutions deployed

across 90+ countries

seconds

chest X-ray analysis time with CAD4TB+

Ghana

National TB screening program implementation

Mozambique

National TB screening program implementation

Nigeria

Leveraging technology for TB screening and healthier future

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

06 · Company updates

Updates from Delft Imaging

Recent articles published on Delft Imaging's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon